Carlsmed, Inc. Accounts Receivable, Allowance for Credit Loss
Carlsmed, Inc. (CARL) had Accounts Receivable, Allowance for Credit Loss of $2.80 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-05
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $2.80M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $2.10M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $1.70M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $1.60M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $2.80M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $2.10M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.70M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $1.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.60M 10-Q · filed 2025-08-28 |
| 2024-12-31 | $1.20M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |